Clear cell kidney cancer gene mutation identified in multicenter study
The gene, called PBRM1, was found to be mutated in 88 cases out of 257 clear cell renal cell carcinomas analyzed
In a collaborative project involving scientists from three continents, researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer. The gene, called PBRM1, was found to be mutated in 88 cases out of 257 clear cell renal cell carcinomas analyzed, making it the most prevalent to be identified in renal cancer in 20 years.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy
- A Review of Immunotherapy in Renal Cell Carcinoma: Current Landscape and Future Directions
- EAU 2025: State-of-the-Art Lecture: Neoadjuvant Strategies in Locally Advanced Renal Cancer
- Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics‑based liquid biopsy assay
- Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)